Tandem Diabetes Care, Inc.
TNDM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $1.01B | $940M | +7.9% |
| Operating income | −$187M | −$99.1M | −88.9% |
| Net income | −$205M | −$96.0M | −113% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $284M | $249M | +13.8% |
| Operating income | −$2.40M | −$22.9M | +89.5% |
| Net income | −$7.10M | −$21.2M | +66.5% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Tandem Diabetes's revenue in FY2025?
- $1.01B in FY2025 (Fiscal year ended Dec 31, 2025), +7.9% vs $940M a year earlier, per its 10-K filed Feb 2026.
- Was Tandem Diabetes profitable in FY2025?
- No: net income was −$205M and operating income −$187M in FY2025.
- What was Tandem Diabetes's revenue in Q3 2026?
- $284M (+13.8% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.